Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GEORGIA CAPITAL PLC Director's Dealing 2020

Sep 29, 2020

5002_dirs_2020-09-29_0f8d9ad6-6043-44f8-8175-c53d61a13698.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 4673A

Georgia Capital PLC

29 September 2020

London, 29 September 2020

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nikoloz Gamkrelidze

2.

Reason for the notification

a)

Position / status

PDMR, CEO of Georgia Healthcare Group PLC

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Georgia Capital PLC

b)

LEI:

213800Q65T5GNBOW7H65

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification Code

Ordinary shares of £0.01 each in Georgia Capital PLC

GB00BF4HYV08

b)

Nature of the transaction

Exercise of nil-cost options over ordinary shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
n/a 17,000

d)

Aggregated information

Aggregated volume

17,000 ordinary shares

Aggregated price

n/a

e)

Dates of the transaction

28 September 2020

f)

Place of the transaction

Outside of a trading venue

Name of authorised official of issuer responsible for making notification: 

Link Company Matters Limited, Company Secretary 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFKLFLBKLXBBL